BIOMAT Database Logo BIOMAT Database Logo

[Clinical aspects of drug interactions. Mechanisms of interactions]. 1976

J Prandota, and M Witkowska

UI MeSH Term Description Entries
D010597 Pharmacogenetics A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION). Pharmacogenomics
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

J Prandota, and M Witkowska
[Clinical aspects of drug-alcohol interactions].
February 1997, Nihon rinsho. Japanese journal of clinical medicine,
J Prandota, and M Witkowska
Clinical Aspects of Transporter-Mediated Drug-Drug Interactions.
June 2019, Clinical pharmacology and therapeutics,
J Prandota, and M Witkowska
[Drug interactions: mechanisms and clinical significance].
January 1989, Srpski arhiv za celokupno lekarstvo,
J Prandota, and M Witkowska
[Drug interactions. Mechanisms and clinical relevance].
November 2003, Der Internist,
J Prandota, and M Witkowska
[Drug interactions: new mechanisms and clinical relevance].
April 2000, Der Internist,
J Prandota, and M Witkowska
Drug-cytokine interactions: mechanisms and clinical implications.
May 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
J Prandota, and M Witkowska
Mechanisms and the clinical relevance of complex drug-drug interactions.
January 2018, Clinical pharmacology : advances and applications,
J Prandota, and M Witkowska
Clinical pharmacology of drug metabolism and drug interactions: clinical, interethnical and regulatory aspects.
January 2013, Drug metabolism and drug interactions,
J Prandota, and M Witkowska
Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
August 2012, Expert opinion on drug metabolism & toxicology,
J Prandota, and M Witkowska
Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.
October 2011, Current cardiology reports,
Copied contents to your clipboard!